McObject Unveils V.7.1 of eXtremeDB Financial Edition to Tackle Regulatory Data Demands

The enhancements in version 7.1 position McObject as a provider of underlying technology to help firms meet MiFID II's best execution requirements and the demands of FRTB.

steve-graves

"The changes are focused on the global financial markets and geared towards reducing the time it takes to load and analyze data. Clients particularly value this for risk management, and of course it helps them meet regulatory requirements such as MiFID II and FRTB, [the Fundamental Review of the Trading Book regulation], both of which demand storage and fast analysis of vast volumes of data," says McObject chief executive co-founder Steve Graves.

To comply with the upcoming FRTB requirements

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

Preparing for the gathering storm

The Markets in Crypto-Assets (Mica) regulation came into force across the European Union on June 29 to enhance the transparency and integrity of the industry’s burgeoning crypto markets. Travis Schwab, CEO of Eventus, discusses his firm’s Mica strategy…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here